THESEUS PHARMACEUTICALS INC (THRX) Forecast, Price Target & Analyst Ratings

NASDAQ:THRX • US88369M1018

Current stock price

4.06 USD
0 (0%)
At close:
4.08 USD
+0.02 (+0.49%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THESEUS PHARMACEUTICALS INC (THRX).

Forecast Snapshot

Consensus Price Target

Price Target
$5.36
+ 31.90% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 7, 2024
Period
Q4 / 2023
EPS Estimate
-$0.30
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
77.78%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.36
Upside
+ 31.90%
From current price of $4.06 to mean target of $5.36, Based on 9 analyst forecasts
Low
$3.54
Median
$5.36
High
$7.35

Price Target Revisions

1 Month
0.00%
3 Months
-21.64%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for THRX. The average price target is 5.36 USD. This implies a price increase of 31.9% is expected in the next year compared to the current price of 4.06.
The average price target has been revised downward by 21.64% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

THRX Current Analyst RatingTHRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

THRX Historical Analyst RatingsTHRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
77.78%
THRX was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about THRX.
In the previous month the buy percentage consensus was at a similar level.
THRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-07-14Cantor FitzgeraldMaintains Overweight -> Overweight
2023-07-14NeedhamDowngrade Buy -> Hold
2023-07-14WedbushMaintains Outperform -> Outperform
2023-07-14HC Wainwright & Co.Maintains Buy -> Buy
2023-05-26NeedhamReiterate Buy -> Buy
2023-05-26HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-17NeedhamReiterate Buy -> Buy
2023-05-12NeedhamReiterate Buy -> Buy
2023-05-12HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-16StifelInitiate Buy
2023-03-10NeedhamReiterate Buy
2023-03-10HC Wainwright & Co.Reiterate Buy
2022-12-14NeedhamInitiate Buy
2022-06-30HC Wainwright & Co.Initiate Buy
2021-11-01Cantor FitzgeraldInitiate Overweight
2021-11-01SVB LeerinkInitiate Outperform
2021-11-01WedbushInitiate Outperform
2021-11-01JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 7, 2024
Period
Q4 / 2023
EPS Estimate
-$0.30
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
15.49%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
19.44%

Next Earnings Summary

THRX is expected to report earnings on 3/7/2024. The consensus EPS estimate for the next earnings is -0.3 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
THRX revenue by date.THRX revenue by date.
N/AN/AN/AN/AN/A
3,419.06%		N/A
154.20%		N/A
12.67%		N/A
10.86%
EBITDA
YoY % growth
THRX ebitda by date.THRX ebitda by date.
-4.94M-6.84M
-38.46%		-27.34M
-299.71%		-54.04M
-97.66%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
THRX ebit by date.THRX ebit by date.
-4.94M-6.84M
-38.46%		-27.34M
-299.71%		-54.09M
-97.84%		N/A
-20.69%		N/A
31.56%		N/A
-15.30%		N/A
-70.07%		N/A
121.99%		N/A
790.61%		N/A
20.60%		N/A
16.37%
Operating Margin
THRX operating margin by date.THRX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
THRX eps by date.THRX eps by date.
N/AN/AN/A-1.30
25.68%		N/A
-0.43%		N/A
26.56%		N/A
24.47%		N/A
-130.52%		N/A
113.75%		N/A
584.44%		N/A
20.78%		N/A
16.13%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.30
15.49%		-0.45
-32.00%		-0.45
-32.00%		-0.42
-36.55%		-0.43
-46.55%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-13.26M
14.34%		-21.318M
-24.96%		-21.318M
-21.19%		-22.134M
-34.96%		-22.134M
-66.92%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

THRX Yearly Revenue VS EstimatesTHRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 100M 200M 300M 400M
THRX Yearly EPS VS EstimatesTHRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.00%
EPS Next 5 Year
16.83%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

THESEUS PHARMACEUTICALS INC / THRX Forecast FAQ

What is the average price target for THESEUS PHARMACEUTICALS INC (THRX) stock?

9 analysts have analysed THRX and the average price target is 5.36 USD. This implies a price increase of 31.9% is expected in the next year compared to the current price of 4.06.

What is the next earnings date for THRX stock?

THESEUS PHARMACEUTICALS INC (THRX) will report earnings on 2024-03-07, after the market close.

Can you provide the consensus estimates for THESEUS PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of THESEUS PHARMACEUTICALS INC (THRX) is -0.3 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for THESEUS PHARMACEUTICALS INC stock?

The consensus rating for THESEUS PHARMACEUTICALS INC (THRX) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.